A K Gupta1, V J Bakanauskas, G J Cerniglia
1Department of Radiation Oncology, University of Pennsylvania, 195 John Morgan Building, 3620 Hamilton Walk, Philadelphia, PA 19104, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
The phosphoinositide-3-kinase (PI3K) pathway enhances tumor cell survival against radiation therapy. Inhibiting PI3K could sensitize tumors to radiotherapy, improving cancer treatment outcomes.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: